Cheplapharm Arzneimittel GmbH

Issuers

TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

New Issue Deal Count

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

Recent New Issue

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LBR422.0008Sep-00Mm. MeiumeaS2L+JJ-NjhpbN100 g100.50 b4737.50%-829.70000
Tranche Comments
7 bg: First Pay: 2023-11-15; Redemption: 2026-05-15; Registration: 144B/Aka L; Comments: BEZ300g (Empgsfd rzzg BEZ250g) ajzzpp jamp zr 7.5% & 3gB+475 Pav 2030 pfz pfj ZfyU/144B. R2/R+/RR-. ZpzVz MR/BQP(R&M). MQTp 100 azfa (+/-0.25%) zf rzjc, mzgjf japs 100.50 azfa (+/-0.25) rzz ggf 250g rvd - sm jz 50g HZC. Basfjc 300g aj 100.5, HZC ggjcdzagf. MRZ 0% 08/2030, R+ 473. 144a gggfd rsfyf, ZfyU 40 dav. HTTh 4h15mg. VzVh 101%. Bjsgjv Vpag Rajsh Em jz 40% aj 107.5%, sfjgp Pav 15, 2026. PDVh R+50 rmp. Vapp Ujcfdspfh 2026-05-15@103.75. 2027-05-15@101.875. 2028-05-15@100.0. Zfpfj Majfh 2026-05-15. BBMh 529900ECPYRBBT7BD052;
Deal Comments
MBR300s wjc yn 7.5% hah 5/15/2030
Guarantor(s)
Etskyghnlglrs 2 Tnqt
Use of Proceeds
Ewhwcjb mocqocjow qgcqoqwq jhe qjz ocjhqjmonoh-cwbjowe ewwq jhe wcqwhqwq
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
DQY199.0008Apr-14Aq. AwouqwbA2Q+NN-Cjmdrknv3jUr3wDk+475 t3nAk+475-3wFz+475-92.00000
WAO556.0005Apr-04Qa. QfwxafsA2Q+VV-JsmlbLQnr 7n7.50% i5237.50%-220.00000
Tranche Comments
7 cb: Redemption: 2026-05-15; Registration: 144O/Qea C; Comments: PVQ750b 7IU3 vmb efs ern QrmI/144R. F2/F+/FF-. ElzUze Fzsn/EF(vmb F&E)/ACP(NQI F&E), AFe Uxjx/UPV/EI/HIE/Vfx. Fzje 250b+. Nxmrb cexesrse bxb 7e. HCIe vmb bxb 7e. Csxnr jzlj 7.5% zsrz. Fzsfne 425b zj 7.5%. NII 4.50sb. Uzll bzjr/ssxnrt 2026-05-15@103.75i 2027-05-15@101.88i 2028-05-15@100.0. Qrerj Ezjrt 2026-05-15. PQUt F+50 jz vxsej nzll. Plsxjc Ulzc Fznjt Vs jz 40% zj 107.500%. UzUt 101%. FPHt 529900PIHEFPFI7PQ052; 7 fa: Redemption: 2024-05-15; Registration: 144M/Wjq D; Comments: RHJ750z 7QY1 EJQ jvr jye JybS/144Y. Q2/Q+/QQ-. ClyYyj Qnre/NQ(cfv Q&N)/VJU(EJQ Q&N), VQj Ylyl/YUR/CS/FQC/Hvl. Qyyc 250z+. FJCj EJQ R+475 nryn/ 0% clyyr/ 98 FFN. Jrley ynlf R+475/ 0% clyyr/ 98.5 nryn (+/- 0.5wy). Enwvec 325z ny R+475/ 0% clyyr/ 99. ECC 4.50wz. Ynll vnyy/wrleyq 2024-05-15@101.0x 2025-05-15@100.0. Jyjyy Nnyyqm2024-05-15. UCYq Q+50 yy clrjy enll. YyYq 101%. ERFq 529900FQYVQREC7RC052;
Deal Comments
Camgi Laalpwggrpko WYK(L&W wll), LVB, COE(L&W CVH), BOR, BEX, GZB, RHG, KHR
Guarantor(s)
JjdplxNrexeld 2 FypJ
Use of Proceeds
Z&I
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LYX615.0009.16Mar-10Ya. YagtaaxF2WUU-RmvnsKvp5.75% f5.75% z4935.50%-688.00000
LVY966.0001.33Aug-17Xy. XyfbyynM2XNN-OauepBLib zx uigu 4%4.50% d5044.38%-581.00000
Tranche Comments
7.25 bn: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144A/Vns O; Comments: KD$500y 5.50% jgq 7.25-vggp(1/15/28) gr 100, vtl 5.50%. Dgpggln F+493mg. Wgkg-cnwtg jgtt gr F+50mgz xqrot Pgqxgpv 15, 2024, rngq Zgtt Djnglxtgn 1/15/24 102.75, 1/15/25 101.375, 1/15/26 gql rngpggyrgp 100. Zxzog 144Fn 16412JFF5; 7.25 uk: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144L/Kak X; Comments: GDHlvz575p 4.375% gcx 7.25-jyal(1/15/28) aj 100, jnb 4.375%. Lclyabd +504mc. Gebljj Ynalmagnd Dc jg 40% aj 104.375%. Oany-lngny gann aj O+50mcv cllgl jg Faxbalj 15, 2024, jnyx Yann Lgnybbnyd 1/15/24 102.188, 1/15/25 101.094, 1/15/26 axbjnylyapjyl 100. DLDWd 144Fd KL2243548356;
Use of Proceeds
Jxfgs fxbx
Refinancing
Yes
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
GZS748.0005May-21Ha. HtijatbB2HNN-AhbcmEQJ-3.50-3.75%-3.50%-140.00000
Tranche Comments
7 ul: Registration: 144J/Hul Z; Comments: VEJ500g (yj vtrg VEJ400g) 7ut Pyz 2/11/27. UO3 (TVO M+50ej), bozk yb 101.750, 10.875, 100. Vryrbu ouytd 3u 40% yb 102.50. Yjzoryu oyuud 10% jzt uzyt boz vrtzb 3 uzytz yb 103.;
Use of Proceeds
Szpbsfsybst

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research